From Investorplace: Although the stock market is trending modestly higher thus far in 2015 — the S&P 500 is up about 3% to date — there’s been more than enough worry to go around, and hunting … [Read more...]

From Kiplinger: We mixed and matched our 20 favorite exchange-traded funds to create five model portfolios to suit most investors' needs. Choosing a good exchange-traded fund is a little like … [Read more...]

From The Street: With Eli Lilly & Co. experimenting with a new drug for Alzheimer's disease, we decided to check Quant Ratings for pharmaceutical stocks to buy. The companies we chose also pay … [Read more...]

From Business Insider: Vivint Solar surged 41% in premarket trading on Monday after news that it was being acquired by SunEdison and TerraForm. This deal will help SunEdison, already a giant in … [Read more...]

From The Street: Earnings season is upon us. To date, 60 S&P 500 components have reported their numbers to Wall Street, and on average, they're overwhelmingly beating expectations. So far, 70% … [Read more...]

From Forbes: When American Pharoah streaked to victory in the Belmont Stakes last month, he became the first horse in 37 years to capture the Triple Crown — and it’s no coincidence that the drought … [Read more...]

From 24/7 Wall Street: The biotech industry has been on an outstanding run over the past year, and some top analysts on Wall Street think that run could be poised to continue. A new research report … [Read more...]

From The Street: There isn't a day that goes by on Wall Street when certain stocks trading for $10 a share don't experience massive spikes higher. Traders savvy enough to follow the low-priced … [Read more...]

From 24/7 Wall Street: Analysts are constantly using quantitative screens to search the stock universe for what is the best-performing category. In a new report from Merrill Lynch’s Savita … [Read more...]